Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In 2008, a letter to the editor in The New England Journal of Medicine described another serendipitous observation of the effect of the nonselective beta-blocker, propranolol, on hemangiomas in 9 cases. This finding has been expanded by the authors of this original observation as well as others.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This study compared the effects of combined treatment using the ARB candesartan and propranolol versus propranolol monotherapy on portal pressure in patients with cirrhosis in a prospective, randomized controlled trial. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Infantile hemangioma is the most common vascular tumor in early childhood. Propranolol has been successfully used recently in a limited number of children with Infantile hemangioma. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso

“…In this review, we discuss the use of propranolol in targeting these receptors in vascular tumors and other cancers.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Propranolol is a highly lipid‐soluble beta‐receptor antagonist and propafenone is a potent class 1c anti‐arrhythmic agent with strong Na‐channel blockade effect. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Propranolol, as the first generation of β-blocker family, was initially introduced in the clinical application for tachycardia and hypertension in the 1960s. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND/OBJECTIVES: The most frequent benign vascular tumor in children is infantile hemangioma (IH). For severe IHs, propranolol has become the first‐line Treatment. Despite the fact that several studies have comprehensive therapy regimens, including the best time to start Treatment, dosage, visit frequency, and treatment duration, there is still controversy about the best time to start and stop propranolol medication. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…15 schizophrenic patients were treated with dl-propranolol in a 4 week open study. Dosage was gradually increased over a period of 17 days to 1920 mg/day. …”
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Propranolol, as a beta-adrenergic blocker is used for treatment of a large number of cardiovascular diseases such as hypertension and arrhythmias. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Propranolol has shown remarkable response rates. There are, however, some adverse effects, which include changes in sleep, acrocyanosis, hypotension, and hypoglycemia. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…There is no definitive conclusion regarding the optimal timing for terminating propranolol treatment for infantile hemangioma (IH). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso

“…We report a case of arterial anatomical variation in which the treatment was propranolol and clonazepam, showing tinnitus improvement.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…OBJECTIVE: This study aims to evaluate the effects of bevacizumab and propranolol from the point of view of a possible antiangiogenic effect in a model of primary nasal polyp (NP) tissue culture. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Treating infantile hemangiomas with oral propranolol may be initiated in accordance with various protocols some require hospitalization. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso